Literature DB >> 7113240

An appraisal of transcatheter arterial embolization combined with transcatheter arterial infusion of chemotherapeutic agent for hepatic malignancies.

J Okamura, S Horikawa, T Fujiyama, M Monden, J Kambayashi, O Sikujara, M Sakurai, C Kuroda, H Nakamura, G Kosaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7113240     DOI： 10.1007/bf01653556

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  9 in total

1.  Results of hepatic lobectomy for primary epithelial cancer in 31 adults.

Authors:  T I Sørensen; K F Aronsen; S Aune; H Baden; A Bergan; M Lempinen; O V Nielsen
Journal:  Am J Surg       Date:  1979-09       Impact factor: 2.565

Review 2.  Recent advances in technique of hepatic lobectomy and results of surgical treatment for primary carcinoma of the liver.

Authors:  T Lin
Journal:  Prog Liver Dis       Date:  1976

3.  Transcatheter occlusion of abdominal tumors.

Authors:  H M Goldstein; S Wallace; J H Anderson; R L Bree; C Gianturco
Journal:  Radiology       Date:  1976-09       Impact factor: 11.105

4.  Primary malignant tumors of the liver.

Authors:  A A el-Domeiri; A G Huvos; H S Goldsmith; F W Foote
Journal:  Cancer       Date:  1971-01       Impact factor: 6.860

Review 5.  Survival after liver resection for cancer.

Authors:  J H Foster
Journal:  Cancer       Date:  1970-09       Impact factor: 6.860

6.  The seventies evolution in liver surgery for cancer.

Authors:  J G Fortner; B J MacLean; D K Kim; W S Howland; A D Turnbull; P Goldiner; G Carlon; E J Beattie
Journal:  Cancer       Date:  1981-05-01       Impact factor: 6.860

7.  Primary liver cancers in Japan.

Authors: 
Journal:  Cancer       Date:  1980-05-15       Impact factor: 6.860

8.  Non-operative arterial embolisation in primary liver tumours.

Authors:  P G Wheeler; W Melia; P Dubbins; B Jones; H Nunnerley; P Johnson; R Williams
Journal:  Br Med J       Date:  1979-07-28

Review 9.  Techniques and therapies for primary and metastatic liver cancer.

Authors:  G B Ong
Journal:  Curr Probl Cancer       Date:  1977-12       Impact factor: 3.187
  9 in total
  17 in total

1.  Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer--a pilot study.

Authors:  K Ikeda; S Saitoh; Y Suzuki; A Tsubota; I Koida; M Kobayashi; Y Arase; K Chayama; N Murashima; H Kumada
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

2.  The role of surgery in the management of unusual complications of transcatheter arterial embolization for hepatocellular carcinoma.

Authors:  K S Jeng; H J Ching
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

3.  Active inflammatory change of the liver as a cause of postoperative hepatic failure.

Authors:  M Sakurai; J Okamura; C Kuroda; T Yamada
Journal:  Jpn J Surg       Date:  1986-11

4.  The Negative Effect of Preoperative Transcatheter Arterial Chemoembolization on Long-Term Outcomes for Resectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

Authors:  Masataka Amisaki; Soichiro Honjo; Masaki Morimoto; Takehiko Hanaki; Yosuke Arai; Naruo Tokuyasu; Teruhisa Sakamoto; Yasufumi Ohuchi; Hiroaki Saito
Journal:  Yonago Acta Med       Date:  2016-12-26       Impact factor: 1.641

5.  Detection of hepatocellular carcinoma capsule by contrast-enhanced ultrasound using Levovist: correlations with pathological findings.

Authors:  Pabitra K Bhattacharjee; Akiko Saito; Michiyo Chiba; Hideo Katsuragawa; Ken Takasaki
Journal:  J Med Ultrason (2001)       Date:  2005-12       Impact factor: 1.314

6.  Intra-arterial administration of epirubicin in the treatment of nonresectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma.

Authors: 
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

7.  Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions.

Authors:  M Monden; M Sakon; M Gotoh; T Kanai; K Umeshita; K S Wang; M Sakurai; C Kuroda; J Okamura; T Mori
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

8.  Efficacy of combination treatment--(TAE with adriamycin and ethanol)--for hepatocellular carcinoma.

Authors:  Y Hasuike; J Okamura; J Furukawa; M Naoi; N Takata; H Maruyama; M Kinuta; E Yayoi; H Oi; S Okamoto
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Treatment response to transcatheter arterial embolization and chemoembolization in primary and metastatic tumors of the liver.

Authors:  Avo Artinyan; Rebecca Nelson; Perry Soriano; Vincent Chung; Janet Retseck; Jonathon Reynolds; Howard Marx; Joseph Kim; Lawrence Wagman
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

10.  Real-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma.

Authors:  Marine Gross-Goupil; Raphaël Saffroy; Daniel Azoulay; Sophie Precetti; Jean-François Emile; Valérie Delvart; Fréderic Tindilière; Alexis Laurent; Marie-France Bellin; Henri Bismuth; Brigitte Debuire; Antoinette Lemoine
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.